The preparation is at the stage of development now. "It's necessary to carry out a number of experiments, launch production," said David Yakobashvili, board chairman of the Wimm Bill Dann company that financed research for the project Anti-AIDS.
"The new medicine will be capable of stopping the disease by means of preventing pathogenic cells from dividing. Thus, the patient who will last about two months is given an opportunity to live much longer," Mr. Yakobashvili said speaking at the international conference "Social Responsibility of Companies." In his words, at first the preparation will be available to rich people. "Treatment is rather costly, but the first results achieved instill hope," Mr. Yakobashvili concluded.